Abstract
OBJECTIVE: In tissue and leiomyoma cells, we previously identified molecular alterations in the retinoic acid (RA) pathway including increased expression of cytochrome P450 26A1 (CYP26A1) which results in decreased intracellular all-trans retinoic acid (ATRA). Exogenous ATRA inhibited proliferation and extracellular matrix production, but systemic use of ATRA therapeutically for women with leiomyomas could be associated with significant toxicity. Liarozole inhibits CYP26A1 activity, resulting in increased intracellular ATRA.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
